Role and function of the 26S proteasome in proliferation and apoptosis

Laboratory Investigation

Volumn 82, Issue 8, 2002, Pages 965-980

  Naujokat, Cord ^a   Hoffmann, Stephan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL CYCLE PROTEIN; CELL PROTEIN; CYCLIN A; CYCLIN D; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; POLYGLUTAMINE; PROTEASOME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P57; TRANSCRIPTION FACTOR E2F; UBIQUITIN;

ALZHEIMER DISEASE; APOPTOSIS; CANCER; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; MUSCULAR DYSTROPHY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; SHORT SURVEY;

EID: 0036678959     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000022226.23741.37     Document Type: Short Survey

References (194)

1. β-catenin is a target for the ubiquitin-proteasome pathway
2. Proteasome inhibitors: A novel class of potent and effective antitumor agents
3. The Bcl-2 protein family: Arbiters of cell survival
4. The p53 network
5. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27
6. Cell cycle-regulated proteolysis of mitotic target proteins
7. The proteasome: Paradigm of a self-compartmentalizing protease
8. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
9. Degradation of α-synuclein by proteasome
10. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progresssion and terminal differentiation
11. Evidence for a role of NF-KB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor β fusion protein
12. WAF1/CIP1 expression
13. The base of the proteasome regulatory particle exhibits chaperone-like activity
14. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathways
15. Ubiquitin-mediated degradation of the proapoptotic form of Bid
16. Regulation of E2F through ubuquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
17. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis
18. Kip1 protein: Prognostic implications in primary breast cancer
19. Kip1 in non-small cell lung carcinoma: A potential prognostic factor independent of ras
20. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
21. Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway
22. Role of proteasome in Alzheimer's disease
23. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis
24. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
25. Kip1 CDK inhibitors are essential activators of cyclin D-dependent kinases in murine fibroblasts
26. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
27. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway
28. The ubiquitin-proteasome pathway: On protein death and cell life
29. The ubiquitin-proteasome pathway: The complexity and myriad function of proteins death
30. Ubiquitin-mediated proteolysis: Biological regulation via destruction
31. Kip1 for restriction point control of the fibroblast cell cycle
32. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
33. Proteasome activation as a critical event of thymocyte apoptosis
34. Developmental changes of the 26S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death
35. Nuclear structure and DNA replication
36. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
37. X-linked IAP is a direct inhibitor of cell-death proteases
38. Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
39. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway
40. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway
41. Activation of the cell death program by inhibition of proteasome function
42. Inhibition of proteasome function induces cell death in proliferating endothelial cells
43. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors
44. Kip1 and the timing of oligodendrocyte differentiation
45. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
46. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
47. Cell death in polyglutamine diseases
48. Lactacystin, proteasome function, and cell fate
49. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
50. A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line
51. Pathological leasons of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome
52. Regulatory subunit interactions of the 26S proteasome, a complex problem
53. Proteasomes are essential for yeast proliferation
54. Rat α-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex
55. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3
56. Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro
57. Binding of amyloid β to the 20S proteasome
58. c-Myc proteolysis by the ubiquitin-proteasome pathay: Stabilization of c-Myc in Burkitt's lymphoma cells
59. The role of the proteasome in apoptotsis
60. Proteasomes play an essential role in thymocyte apoptosis
61. Structure of 20S proteasome from yeast at 2.4 A resolution
62. Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells
63. Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway
64. Skipping into the E2F1-destruction pathway
65. Molecular regulation of muscle cachexia: It may be more than the proteasome
66. Autosomal recessive juvenile parkinsonism: A key to understanding nigral degeneration in sporadic Parkinson's disease
67. Proteinase yscE, the yeast proteasome/multicatalytic multifunctional proteinase: Mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival
68. The biochemistry of apoptosis
69. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
70. Comparison of human COP9 signalosome and 26S proteasome lid
71. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
72. The ubiquitin system
73. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis
74. Roles of proteasomes in cell growth
75. Regulation of proteasome expression in developing and transformed cells
76. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly
77. An unfolded putative polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin
78. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
79. Characterization of NF-KB expression in Hodgkin's disease: Inhibition of constitutively expressed NF-κB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells
80. Changes in the structure and function of the multicatalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta
81. The proteasome is involved in the first metaphase-to-anaphase transition of miosis in rat oocytes
82. Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation
83. Changes in expression of proteasome and ubiquitin genes in human renal cancer cells
84. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
85. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle and apoptosis
86. Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes
87. Inhibiting proteasome activity causes overreplication of DNA and blocks entry into mitosis in sea urchin embryos
88. Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
89. Impaired proteasome function in Alzheimer's disease
90. Progress in the clinical and molecular genetics of familial parkinsonism
91. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
92. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells
93. Cell-specific accumulation of Drosophila proteasomes (MCP) during early embryonal development
94. How the cyclin became a cyclin: Regulated proteolysis in the cell cycle
95. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
96. -/- colon carcinoma
97. P27(Kip1) accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells
98. Proteasome expression in the skeletal muscles of patients with muscular dystrophy
99. Abnormally high expression of proteasomes in human leukemic cells
100. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease
101. Proteasome inhibitors: Valuable new tools for cell biologists
102. p53, the cellular gatekeeper for growth and division
103. Bax degradation by the ubiquitin/ proteasome-dependent pathway: Involvement in tumor survival and progression
104. Cotranslational biogenesis of NF-KB p50 by the 26S proteasome
105. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
106. p53-dependent induction of apoptosis by proteasome inhibitors
107. Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta
108. Crystal structure of the 20S proteasome from the archeon T. acidophilum at 3.4 A resolution
109. Cell cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
110. In vivo ubiquitination and proteasome-mediated degradation of p53
111. The ubiquitin-proteasome sytem in cell cycle control
112. Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate Aβ42 recovery from human cells
113. Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells
114. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation
115. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease
116. Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes
117. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex
118. Requirement of NF-KB activation to suppress p53-independent apoptosis induced by oncogenic Ras
119. Geminin, an inhibitor of DNA replication, is degraded during mitosis
120. Cell fate decisions in the early embryo of the nematode Caenorhabditis elegans
121. Proteasomal function is impaired in substantia nigra in Parkinson's disease
122. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
123. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2
124. Activation of β-catenin Tcf-signaling in colon cancer by mutations in β-catenin and APC
125. Signaling pathways that establish the dorsal-ventral pattern of the Drosophila embryo
126. WAF1/Cip1 in human immature leukemic cells
127. Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome
128. Cip1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro
129. Analysis of expresssion of nuclear factor kappa B (NF-KB) in multiple myeloma: Downregulation of NF-κB induces apoptosis
130. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
131. The role of the ubiquitin-proteasome pathway in apoptosis
132. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
133. Control of gene expression by proteolysis
134. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
135. Cell cycle- and cell growth-regulated proteolysis of mammalian Cdc6 is dependent on APC-Cdhl
136. Proteasome-dependent degradation of p27/kip1 in gliomas
137. Kip1 and cyclin E, alone or in combination, correlate with survival in young breast cancer patients
138. APC mutations occur during colorectal tumorigenesis
139. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons
140. CPEB degradation during oocyte maturation requires a PEST domain and the 26S proteasome
141. Proteasomal inhibition leads to formation of ubiquitin/α-synuclein-immunoreactive inclusions in PC12 cells
142. WAF1 in human melanoma cells
143. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer
144. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
145. The neurite-initiation effect of a tripeptide aldehyde protease inhibitor on PC12h cells
146. Defective ubiquitination of cerebral proteins in Alzheimer's disease
147. The 26S assembly is regulated by a maturation-induced hormone in starfish oocytes
148. The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p53
149. Kip1, in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
150. Hormonal control of rates of metamorphic development in the tobacco hornworm Manduca sexta
151. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits
152. Increased β-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo
153. Kip1 and its alteration in tumor cells: A review
154. Cip1 ubiquitination
155. WAF1/Cip1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines
156. CDK inhibitors: Positive and negative regulators of Gl-phase progression
157. Regulation of gene expression of proteasomes (multiprotease complexes) during growth and differentiation of human hematopoietic cells
158. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
159. Apoptosis induction resulting from proteasome inhibition
160. Kip1 by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
161. Cullin-3 targtes cyclin E for ubiquitination and controls S-phase in mammalian cells
162. The cellular response to p53: The decision between life and death
163. Regulation of the Cdk inhibitor p27 and its deregulation in cancer
164. The ubiquitin-proteasome pathway in cancer
165. Retinoid acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation
166. Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome
167. Kip1 degradation and induces S phase in quiescent cells
168. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death
169. Tricorn protease in bacteria: Characterization of the enzyme from Streptomyces coelicor
170. Parkin is linked to the ubiquitin pathway
171. Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
172. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells
173. Cut8, essential for anaphase, controls localization of 26S proteasome, facilitating destruction of cyclin and Cut2
174. Ubiquitin/proteasome-mediated degradation of p19(INK 4d) determines its periodic expression during the cell cycle
175. α-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
176. Disappearance of a novel protein component of the 26S proteasome during Xenopous oocyte maturation
177. Kip1 is instigated by Jab1
178. Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: A novel catalytic activity in proteasome
179. Differential Inhibition of calpain and proteasome activities by aldehydes of di-leucine and tri-leucine
180. Proteolysis and the cell cycle: With this RING I do thee destroy
181. Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1
182. Rel/NK-κB/IκB family: Intimate tales of association and dissociation
183. The 26S proteasome: A molecular machine designed for controlled proteolysis
184. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
185. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL-60 cells
186. Kip1 overexpression causes apoptotic death of mammalian cells
187. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex
188. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer
189. Culprits in the degradation of cyclin E apprehended
190. Physical association of ubiquitin ligases and the 26S proteasome
191. Ubiquitin protein ligase of IAPs and their degradation in proteasomes in response to apoptotic stimuli
192. Ubiquitin-mediated proteolysis of vertebrate Gl- and S-phase regulators
193. Controlling cell proliferation in differentiation: Genetic analysis of negative regulators of G1→S-phase progression
194. The role of maternal VegT in establishing the primary germ layers in Xenopus embryos